RADIOLOGICAL AND PATHOLOGICAL RESPONSE TO NEOADJUVANT NIVOLUMAB IN PATIENTS WITH BCLC A HCC TREATED BY CURATIVE PERCUTANEOUS IRREVERSIBLE ELECTROPORATION: PRELIMINARY REPORT FROM THE FRENCH MULTICENTRE PHASE 2 NIVOLEP TRIAL. - Institut de Recherche en Cancérologie de Montpellier Access content directly
Conference Papers Year :

RADIOLOGICAL AND PATHOLOGICAL RESPONSE TO NEOADJUVANT NIVOLUMAB IN PATIENTS WITH BCLC A HCC TREATED BY CURATIVE PERCUTANEOUS IRREVERSIBLE ELECTROPORATION: PRELIMINARY REPORT FROM THE FRENCH MULTICENTRE PHASE 2 NIVOLEP TRIAL.

Eric Vicaut
Fichier principal
Vignette du fichier
file GS45.pdf (230.63 Ko) Télécharger le fichier
file GS45 (1).pdf (230.63 Ko) Télécharger le fichier
file GS45 (2).pdf (230.63 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03903631 , version 1 (20-02-2023)

Identifiers

  • HAL Id : hal-03903631 , version 1

Cite

Pierre Nahon, Olivier Seror, Frederic Oberti, Solohaja Faniaha Dimby, Christophe Aube, et al.. RADIOLOGICAL AND PATHOLOGICAL RESPONSE TO NEOADJUVANT NIVOLUMAB IN PATIENTS WITH BCLC A HCC TREATED BY CURATIVE PERCUTANEOUS IRREVERSIBLE ELECTROPORATION: PRELIMINARY REPORT FROM THE FRENCH MULTICENTRE PHASE 2 NIVOLEP TRIAL.. ILCA Annual Conference, 2020, Sep 2020, Bruxelles, Belgium. ⟨hal-03903631⟩
8 View
7 Download

Share

Gmail Facebook Twitter LinkedIn More